Yongqiang Wang Selected Research

Mouth Neoplasms (Oral Cancer)

12/2020	AP-002: A novel inhibitor of osteoclast differentiation and function without disruption of osteogenesis.
1/2017	VP2 of Infectious Bursal Disease Virus Induces Apoptosis via Triggering Oral Cancer Overexpressed 1 (ORAOV1) Protein Degradation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongqiang Wang Research Topics

Disease

61	Infections 03/2024 - 11/2010
29	Neoplasms (Cancer) 02/2024 - 02/2013
14	Virus Diseases (Viral Diseases) 01/2023 - 01/2013
10	Inflammation (Inflammations) 02/2024 - 01/2017
8	Carcinogenesis 12/2023 - 01/2012
7	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 03/2015
7	Sepsis (Septicemia) 02/2022 - 02/2018
5	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2019
5	Fibrosis (Cirrhosis) 01/2022 - 11/2009
5	Urinary Bladder Neoplasms (Bladder Cancer) 09/2020 - 02/2014
4	Marek Disease (Marek's Disease) 06/2023 - 01/2019
4	Wounds and Injuries (Trauma) 01/2022 - 01/2014
4	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2016
4	Poisoning 05/2015 - 04/2008
3	Hypersensitivity (Allergy) 02/2024 - 08/2008
3	Esophageal Squamous Cell Carcinoma 03/2023 - 01/2020
3	Bites and Stings (Sting) 01/2023 - 01/2019
3	Squamous Cell Carcinoma of Head and Neck 11/2022 - 01/2020
3	Brain Injuries (Brain Injury) 01/2022 - 01/2018
3	Ischemia 10/2019 - 01/2017
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 07/2017 - 01/2012
3	Multiple Sclerosis 07/2017 - 01/2012
3	Vesicular Stomatitis 01/2017 - 09/2013
3	Viremia 03/2015 - 03/2012
2	Kyphosis 10/2023 - 11/2021
2	Tics (Tic) 08/2023 - 03/2010
2	Chordoma 06/2023 - 09/2017
2	Lung Injury 10/2022 - 05/2017
2	Pancreatitis 10/2022 - 01/2021
2	Critical Illness (Critically Ill) 08/2022 - 01/2021
2	Premature Ejaculation 06/2022 - 11/2021
2	Fatigue 06/2022 - 04/2021
2	Male Infertility (Male Sterility) 04/2022 - 01/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 01/2022
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2016
2	Cardiomegaly (Heart Hypertrophy) 12/2021 - 07/2019
2	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 01/2019
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 11/2015
2	Mouth Neoplasms (Oral Cancer) 12/2020 - 01/2017
2	Escherichia coli Infections 10/2020 - 09/2008
2	Stomach Neoplasms (Stomach Cancer) 08/2020 - 12/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 01/2020
2	Lymphoma (Lymphomas) 01/2020 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2012
15	MicroRNAs (MicroRNA)IBA 02/2024 - 02/2013
14	VaccinesIBA 09/2022 - 03/2012
11	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 01/2012
11	Interferon Type IIBA 01/2023 - 01/2013
11	CytokinesIBA 10/2019 - 09/2008
7	Messenger RNA (mRNA)IBA 02/2024 - 07/2014
7	Cisplatin (Platino)FDA LinkGeneric 06/2023 - 01/2012
7	Antiviral Agents (Antivirals)IBA 01/2023 - 08/2013
6	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2016
5	RNA (Ribonucleic Acid)IBA 06/2023 - 01/2018
5	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2015
5	Interleukin-6 (Interleukin 6)IBA 10/2019 - 09/2008
4	CollagenIBA 01/2022 - 02/2015
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 09/2008
4	DNA VaccinesIBA 09/2013 - 04/2013
3	Amino Acids FDA Link 02/2024 - 01/2011
3	Long Noncoding RNAIBA 03/2023 - 07/2019
3	scinderinIBA 01/2023 - 06/2015
3	Microfilament Proteins (Actin Binding Proteins)IBA 01/2023 - 11/2015
3	AntioxidantsIBA 10/2022 - 01/2018
3	C-Reactive ProteinIBA 08/2022 - 07/2020
3	Immunoglobulin G (IgG)IBA 06/2022 - 04/2013
3	salicylhydroxamic acid (SHAM)IBA 02/2022 - 01/2014
3	LipopolysaccharidesIBA 07/2020 - 05/2017
3	InterferonsIBA 01/2019 - 03/2015
3	Interleukin-18 (Interleukin 18)IBA 01/2019 - 04/2013
3	XuebijingIBA 05/2015 - 11/2014
2	AcidsIBA 02/2024 - 01/2022
2	Peptides (Polypeptides)IBA 01/2024 - 01/2017
2	AntibodiesIBA 12/2023 - 01/2017
2	Fructose-Bisphosphate Aldolase (Aldolase)IBA 12/2023 - 12/2021
2	Neutralizing AntibodiesIBA 01/2023 - 01/2014
2	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 09/2022 - 01/2019
2	Serine Proteases (Serine Protease)IBA 01/2022 - 01/2022
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 12/2021 - 11/2015
2	Sirtuin 2IBA 01/2021 - 07/2020
2	InflammasomesIBA 01/2021 - 05/2017
2	Tumor Biomarkers (Tumor Markers)IBA 12/2019 - 07/2014
2	Oncogene Proteins (Oncogene Protein)IBA 01/2019 - 01/2017
2	Interferon-betaIBA 01/2019 - 01/2019
2	Viral DNAIBA 01/2019 - 01/2019
2	InterleukinsIBA 12/2018 - 12/2016

Therapy/Procedure

14	Therapeutics 01/2024 - 08/2013
9	Drug Therapy (Chemotherapy) 11/2022 - 01/2015
4	Electroacupuncture 02/2024 - 10/2019
3	Ligation 02/2022 - 01/2013
3	Punctures 02/2022 - 01/2022
2	Acupuncture Points (Acupuncture Point) 02/2024 - 10/2019
2	Immunotherapy 12/2023 - 05/2018
2	Nanospheres 09/2023 - 01/2020
2	Radiotherapy 02/2022 - 01/2021
2	Craniotomy 01/2022 - 01/2021
2	Anesthesia 01/2022 - 01/2014
2	Adjuvant Chemotherapy 01/2021 - 01/2020
2	Intraperitoneal Injections 09/2019 - 02/2018